Published in Transpl Immunol on August 30, 2012
Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant (2014) 1.29
Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) (2014) 0.81
Late and chronic antibody-mediated rejection: main barrier to long term graft survival. Clin Dev Immunol (2013) 0.79
The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. J Immunol Res (2014) 0.76
Immunologic and non-immunologic complications of a third kidney transplantation. Korean J Intern Med (2015) 0.75
Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppression. Pediatr Nephrol (2014) 0.75
Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med (2010) 11.05
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol (1998) 8.40
Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol (2002) 3.34
CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res (2003) 2.40
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Humoral theory of transplantation. Am J Transplant (2003) 2.04
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet (2005) 2.02
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant (2006) 1.78
Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol (1999) 1.77
Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol (2001) 1.72
Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation (2007) 1.54
The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol (2009) 1.48
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant (2007) 1.44
Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation (2007) 1.41
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol (2001) 1.36
Transplant glomerulopathy. Am J Transplant (2008) 1.29
Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant (2008) 1.27
Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant (2005) 1.18
Rituximab for idiopathic membranous nephropathy: who can benefit? Clin J Am Soc Nephrol (2006) 1.18
Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant (2008) 1.11
Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol (2009) 1.11
Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int (2005) 1.10
Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation (1991) 1.00
Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation (2001) 0.98
Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy. Scand J Immunol (2007) 0.98
Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates. Am J Transplant (2006) 0.92
Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant (2006) 0.88
Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study. Hum Pathol (2000) 0.87
Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol (1993) 0.85
De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature. Am J Kidney Dis (1989) 0.80
De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney. Clin Transplant (2011) 0.79
Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries. Clin Transplant (2004) 0.77
Recurrence of de novo membranous glomerulonephritis on renal grafts. Clin Nephrol (1994) 0.77
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Strategies to improve long-term outcomes after renal transplantation. N Engl J Med (2002) 6.76
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood (2004) 2.89
A data model and database for high-resolution pathology analytical image informatics. J Pathol Inform (2011) 2.54
Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int (2003) 2.40
Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol (2011) 2.17
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant (2006) 1.86
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood (2003) 1.79
Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation (2002) 1.75
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int (2011) 1.73
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72
Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol (2009) 1.70
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant (2004) 1.54
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52
Clinical role of the renal transplant biopsy. Nat Rev Nephrol (2012) 1.46
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation (2003) 1.41
Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biol Blood Marrow Transplant (2003) 1.35
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor. Blood (2005) 1.24
Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol (2005) 1.22
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation (2003) 1.19
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int (2005) 1.17
Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12
Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol (2008) 1.11
Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation (2010) 1.10
Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol (2009) 1.10
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Exp Hematol (2007) 1.07
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults. Transfusion (2009) 1.06
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. J Immunol (2011) 0.98
Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis. PLoS One (2013) 0.96
Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer. Cancer Lett (2013) 0.94
The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma. Mod Pathol (2011) 0.93
Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity. J Immunol (2011) 0.93
C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant (2005) 0.92
Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma. Ann Surg Oncol (2011) 0.91
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int (2006) 0.91
Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation (2006) 0.91
Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol (2008) 0.91
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation. Transplantation (2011) 0.91
Liver steatosis assessment: correlations among pathology, radiology, clinical data and automated image analysis software. Pathol Res Pract (2013) 0.90
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? Transplantation (2005) 0.90
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3. Angiogenesis (2013) 0.88
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87
Adults with Sotos syndrome: review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person. Am J Med Genet A (2011) 0.87
Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol (2004) 0.86
Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality. J Immunol (2011) 0.86
Closure of high-volume arteriovenous fistulas improves kidney allograft function in patients with right heart failure. Transpl Int (2009) 0.85
Inhibition of IKKβ in enterocytes exacerbates sepsis-induced intestinal injury and worsens mortality. Crit Care Med (2013) 0.85
Clinical and pathological analysis of colonic Crohn's disease, including a subgroup with ulcerative colitis-like features. Mod Pathol (2011) 0.85
HER2 in resected gastric cancer: Is there prognostic value? J Surg Oncol (2013) 0.84
Eosinophilic granulomatous gastrointestinal and hepatic abscesses attributable to basidiobolomycosis and fasciolias: a simultaneous emergence in Iraqi Kurdistan. BMC Infect Dis (2013) 0.84
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. Transplantation (2006) 0.84
Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging. J Magn Reson Imaging (2012) 0.82
Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplant. Cytokines Cell Mol Ther (2002) 0.82
Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis. Histopathology (2009) 0.82
Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs. J Immunol (2002) 0.82
Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant (2006) 0.81
Accurate, fast, and convenient measurement of glomerular filtration rate in potential renal transplant donors. Transplantation (2010) 0.81
Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus. Virchows Arch (2014) 0.80
Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity. Transplantation (2016) 0.80
Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports. Clin Transpl (2009) 0.80
Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay. Am J Clin Pathol (2008) 0.79
Oxaliplatin-induced hepatoportal sclerosis, portal hypertension, and variceal bleeding successfully treated with transjugular intrahepatic portosystemic shunt. Clin Colorectal Cancer (2012) 0.79
Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma. Cancer (2013) 0.78
CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes. Transplantation (2003) 0.78
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant (2004) 0.78
Hepatoid adenocarcinoma of the lung: a case report and review of the literature. J Gastrointest Cancer (2014) 0.78
Emerging role of B cells in chronic allograft dysfunction. Kidney Int Suppl (2010) 0.78
Expansion and somatic hypermutation of B-cell clones in rejected human kidney grafts. Transplantation (2014) 0.77
Case records of the Massachusetts General Hospital. Case 21-2009. A 61-year-old woman with abdominal pain, weight loss, and renal failure. N Engl J Med (2009) 0.77
Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. Transplantation (2015) 0.76
Concomitant herpes simplex virus colitis and hepatitis in a man with ulcerative colitis: Case report and review of the literature. Medicine (Baltimore) (2016) 0.76
Hypergastrinemia, type 1 gastric carcinoid tumors: diagnosis and management. J Clin Oncol (2011) 0.75
Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies. Am J Transplant (2004) 0.75
New answers to old conundrums: what antibodies, exosomes and inflammasomes bring to the conversation. Canadian National Transplant Research Program international summit report. Transplantation (2017) 0.75
Honokiol Increases CD4+ T Cell Activation and Decreases TNF but Fails to Improve Survival Following Sepsis. Shock (2017) 0.75
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia. Eur J Haematol (2008) 0.75
Dynamics of B cell recovery following kidney/bone marrow transplant recipients. Transplantation (2017) 0.75
Evolution of chronic antibody mediated-rejection: a case report. Clin Transpl (2006) 0.75
Clinicopathologic Features and Outcome of Young Adults With Stage IV Colorectal Cancer. Am J Clin Oncol (2015) 0.75
My most interesting cases. Clin Transpl (2006) 0.75